Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications in diabetes? The FACULTY protocol of a retrospective real-world cohort study.

BMJ open·2025

Same author

Subnational estimates of vitamin A supplementation coverage in children: a geospatial analysis of 45 low- and middle-income countries.

Public health·2024

Same author

Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [<sup>18</sup>F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors.

Cancer imaging : the official publication of the International Cancer Imaging Society·2022

Same author

Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients.

BMC cancer·2022

Same author

The sodium iodide symporter (NIS): novel applications for radionuclide imaging and treatment.

Endocrine-related cancer·2021

Same author

[COVID-19 associated pneumonia despite repeatedly negative PCR-analysis from oropharyngeal swabs].

Pneumologie (Stuttgart, Germany)·2020

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

[Graves' ophthalmopathy from the internist's perspective].

K Laubner¹, W A Weber, J Seufert

¹Schwerpunkt Endokrinologie und Diabetologie, Abteilung Innere Medizin II, Universitätsklinikum Freiburg, Deutschland.

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft

|May 19, 2011

Summary

Graves' orbitopathy (GO) is a common complication of Graves' disease, linked to TSH receptor autoantibodies (TRAb). Effective management of hyperthyroidism and lifestyle changes like smoking cessation are crucial for improving GO outcomes.

More Related Videos

Grossing of Non-neoplastic Globes, Including Fetal Eyes

Grossing of Non-neoplastic Globes, Including Fetal Eyes

Published on: May 30, 2025

Related Experiment Videos

Last Updated: Jun 1, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Grossing of Non-neoplastic Globes, Including Fetal Eyes

Grossing of Non-neoplastic Globes, Including Fetal Eyes

Published on: May 30, 2025

Area of Science:

Endocrinology
Ophthalmology
Immunology

Context:

Graves' orbitopathy (GO) affects up to 40% of patients with Graves' disease.
TSH receptor autoantibodies (TRAb) are key diagnostic markers and play a central role in GO pathogenesis.

Purpose:

To outline the diagnostic criteria for Graves' disease and its extrathyroidal manifestations.
To discuss current therapeutic strategies for hyperthyroidism and their impact on Graves' orbitopathy.
To highlight the challenges in managing Graves' orbitopathy and the need for multidisciplinary care.

Summary:

Diagnosis of Graves' disease involves hyperthyroidism symptoms, low TSH, altered fT3/fT4, and positive TRAbs.
Treatment of hyperthyroidism with antithyroid drugs often improves GO; smoking cessation is vital.
Advanced treatments include radioiodine therapy or thyroid surgery for persistent hyperthyroidism.

Impact:

Emphasizes regular screening for extrathyroidal manifestations, particularly GO, in Graves' disease patients.
Underscores the necessity of a multidisciplinary team approach for comprehensive GO management.
Highlights the clinical challenge posed by Graves' orbitopathy, requiring coordinated specialist involvement.